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A B S T R A C T
A 77-year-old Japanese woman underwent bioprosthetic aortic valve replacement (AVR) and the Maze
procedure for severe aortic valve disease and paroxysmal atrial ﬁbrillation (AF), and one year after the AVR,
she also underwent a permanent pacemaker implantation for sick sinus syndrome. At two postoperative
years, a large mural mass happened to be detected in her left atrium on routine trans-thoracic
echocardiography. The cardiac rhythm records produced by the implanted pacemaker demonstrated the
recurrence of AF. As anticoagulant therapy was not effective at reducing the size of the mass, surgery was
performed and organized thrombus was detected on the ablation line made at the Maze procedure.
<Learning objective: The formation of large mural thrombi in the left atrium after the Maze procedure is
rare in patients without mitral valve disease. The thrombus was considered to have been caused by
several complex factors, including atrial wall damage brought by the Maze procedure and the recurrence
of atrial ﬁbrillation (AF). It is important to be aware that the recurrence of AF after the Maze procedure
can carry a risk of unexpected mural thrombus formation in the left atrium.>
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Atrial ﬁbrillation (AF) is a major cause of thrombus formation
in the left atrium, especially in the left atrial appendage (LAA).
The Maze procedure is effective at maintaining sinus rhythm for
those patients with AF, and consequently, preventing thrombus
formation [1]. Although arrhythmia, e.g. sinus bradycardia, is a
well-known postoperative complication of the Maze procedure [2],
only a few reports have described thrombus formation in the left
atrium (LA) after this procedure [3,4]. We experienced a case in
which a rare appearance of a large mural thrombus was detected in
the LA as late as two years after the Maze procedure. The thrombus
was considered to have been caused by several complex factors,
including atrial wall damage brought by the Maze procedure and
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A 77-year-old Japanese woman with paroxysmal AF and severe
aortic valve stenosis and regurgitation underwent bioprosthetic
aortic valve replacement (AVR) and the Maze procedure. On left side
Maze procedure, the LA was opened via right lateral approach.
Bipolar radio-frequency ablation was applied for isolation of
bilateral pulmonary veins, and also between LAA and the origin
of the left upper pulmonary vein. Because she continued to exhibit a
sinus rhythm postoperatively, she was administered only warfarin
for three months after the operation. One year after the AVR, a
permanent dual chamber (DDD) pacemaker implantation for sick
sinus syndrome was performed. Recurrence of AF had not yet been
conﬁrmed at that time. Transmitral Doppler demonstrated abnor-
mal relaxation pattern (E = 0.76 m/s, A = 0.87 m/s, E/A = 0.87). LA
volume was calculated with 92 ml (volume index: 70.6 ml/m2).
Another year has passed after the implantation of the DDD
pacemaker, and routine trans-thoracic echocardiography (TTE)
was performed. We accidentally discovered a large high echoic
mass adhering to the posterior wall of the LA (Fig. 1A).s reserved.
Fig. 1.
(A) A large roundish high echoic mass adhered to the posterior wall of the left atrium on apical 4-chamber view on trans-thoracic echocardiography. (B) Trans-
esophageal echocardiography demonstrated a homogenous ﬁxed mass with a smooth surface.
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(54%) (left ventricular end-diastolic/end-systolic dimension:
38.7/24.0 mm). No signiﬁcant mitral valve stenosis or regurgitation
had been involved. LA volume was calculated as 116 ml (volume
index: 89.0 ml/m2). Transmitral Doppler demonstrated pseudonor-
malization pattern (E = 0.87 m/s, A = 0.62 m/s, E/A = 1.40) at this
time. Trans-esophageal echocardiography (TEE) detected a large
immobile mural mass (22 mm  27 mm) that had adhered to the
posterior wall of the left atrium (Fig. 1B). The emptying velocity of
the LAA was measured as 35 cm/s. Contrast-enhanced computed
tomography (CT) showed a homogenous mass that did not exhibit a
stalk-like morphology (Fig. 2). The cardiac rhythm records produced
by the DDD pacemaker demonstrated that AF had recurred around
six months earlier.
At ﬁrst, we started anticoagulant therapy with both heparin
and warfarin. The dose of warfarin was adjusted so that the
patient’s prothrombin time-international normalized ratio (PT-INR)
remained between 2.0 and 3.0. Although the warfarin treatment was
continued for more than one month, it did not reduce the size of theFig. 2.
Contrast-enhanced cardiac computed tomography demonstrated a homoge
(B) Sagittal section.mass. Therefore, we decided to remove the mass surgically for fear
that it could increase the patient’s risk of systemic embolization.
The LA was opened via a trans-septal approach. A brownish
relatively hard mass was seen on the posterior wall of the LA. It was
located on the ablation line which had been made with a bipolar
radio-frequency device at the Maze procedure (Fig. 3A and C). As
the mass did not adhere tightly to the atrial wall, it was removed
easily with forceps (Fig. 3B). The mass was pathologically proven to
be an organized thrombus. After the operation, we continued to
administer warfarin to ensure that the patient’s PT-INR remained
between 2.0 and 3.0. Her condition remained stable postopera-
tively, and she was safely discharged after cardiac rehabilitation.
Discussion
We report a case in which a large mural thrombus developed in
the LA of a patient without mitral valve disease two years after she
had undergone the Maze procedure. Anticoagulant therapy was
not effective at reducing the size of the thrombus, and so surgicalnous mass that did not exhibit a stalk-like morphology. (A) Horizontal section.
Fig. 3.
(A) Intraoperative ﬁndings of the mass in the left atrium. (B) The excised mass specimen was brownish and relatively hard. (C) A schema of radio-frequency
ablation map on Maze procedure and relative position of mural thrombus formation in left atrium.
S. Taminishi et al. / Journal of Cardiology Cases 13 (2016) 52–5554thrombectomy was required. We learned several important
clinical suggestions from this case.
The ﬁrst implication is the importance of a differential diagnosis
about those masses detected in the LA. It is generally considered
that masses detected in the atrium can be thrombi, tumors, or
cardiac vegetation. LA thrombi generally form in the LAA, and
cardiac myxoma often exhibits a stalk-like morphology. Vegeta-
tion is easy to be formed on the injured wall on which regurgitant
or shunt ﬂow is colliding. TEE and CT are useful modalities for
determining the characteristics of masses in the LA [5,6]. In the
present study, TEE detected a large high echoic immobile mass
adhering to the posterior wall of the LA. Signiﬁcant mitral valve
disease or congenital heart disease was not evident. And the
mass did not exhibit a stalk-like morphology on CT. With exclusion
diagnosis, we determined that the mass must be a thrombus and
started anticoagulant therapy. However, as the thrombus had
already become organized, it might not have been possible to
dissolve it.
The second implication is that large LA mural thrombi can form
in patients without mitral valve disease as late as two years after
the Maze procedure. Although there have been many reports about
the formation of large atrial thrombi in patients with mitral valve
disease [7], there have only been a few reports about such
complications after the Maze procedure. For example, Aoyagi et al.
reported a case in which a LA thrombus formed a few months after
the Maze procedure and mitral valve repair [3]. Our case differs
from the previous report; in that the patient did not have mitral
valve disease and the thrombus formed much later after surgery.The risk factors for thrombus formation in the atrium are
generally considered to include atrial wall damage, congested
blood ﬂow, coagulation disorders, and dilation of the atrial
chamber. The large mural thrombus seen in the present case
was located along the ablation line which had been made with a
bipolar radio-frequency device at the Maze procedure. Moreover,
transmitral Doppler demonstrated the transition from abnormal
relaxation pattern (one-year after the Maze procedure) to
pseudonormalization pattern (two years after the Maze procedure)
before and after thrombus formation in the LA. And also during this
period, the patient’s DDD pacemaker records demonstrated
recurrent paroxysmal AF. Therefore, we concluded that the
recurrent AF had induced worsening of diastolic dysfunction
and dilated atrial chamber, triggering the formation of the mural
thrombus along the ablation line on the atrial wall. The patient in
our case was classiﬁed with CHADS2 score of 2 points (Congestive
heart failure and Age). Electrophysiologists continue anticoagula-
tion therapy even after successful AF ablation for patients with
CHADS2 score of more than 2 points. Therefore, we should have
continued anticoagulation therapy even after successful Maze
procedure in our case.
The third implication is how to deal with this type of atrial
mass. As atrial thrombi are known to result in a high risk of
systemic embolization, it is necessary to deal with such thrombi
before embolic events occur. However, no guidelines about the
management of LA thrombi have been published. Some previous
studies have found that anticoagulant therapy was useful for
treating atrial thrombi [8]. Others have demonstrated that surgical
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therapy can result in the partial fragmentation or partial
detachment of atrial thrombi, both of which carry a risk of
thromboembolism [10]. On the other hand, surgical removal itself
can also become a risk of thromboembolism. Therefore, the
indications for surgical treatment for atrial thrombi need to be
carefully determined.
In conclusion, we demonstrated a case in which a rare
appearance of a large mural atrial thrombus developed in a
patient without mitral valve disease as late as two years after the
Maze procedure. It is important to be aware that recurrent AF after
the Maze procedure can result in an increased risk of unexpected
mural thrombus formation along the surgical incision line in the
atrial wall. Optimal anticoagulation therapy is thought to be
indispensable for preventing thrombus formation in the LA
according to the risk stratiﬁcation of thrombus even after
successful Maze procedure.
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